Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kasper K Berthelsen"'
Autor:
David C.W. Lau, Domenica Rubino, Kasper K Berthelsen, Michael T. Lund, Martin Kankam, Altynai Satylganova, Lone B Enebo
Publikováno v:
The Lancet. 397:1736-1748
Summary Background Cagrilintide, a long-acting amylin analogue, and semaglutide 2·4 mg, a glucagon-like peptide-1 analogue, are both being investigated as options for weight management. We aimed to determine the safety, tolerability, pharmacokinetic
Autor:
Lone B Enebo, Martin Kankam, David C.W. Lau, Michael T. Lund, Kasper K Berthelsen, Domenica Rubino, Altynai Satylganova
Publikováno v:
Journal of the Endocrine Society
Background: Combining weight management medications with different modes of action may provide more effective treatment options for people with obesity. Subcutaneous (sc) AM833, a long-acting amylin analog, and sc semaglutide 2.4 mg, a glucagon-like
Autor:
Olsen HB; Department of Biology, University of Copenhagen, Universitetsparken 15, 2100 Copenhagen Ø, Denmark., Berthelsen K, Andersen HV, Søchting U
Publikováno v:
Environmental pollution (Barking, Essex : 1987) [Environ Pollut] 2010 Feb; Vol. 158 (2), pp. 455-61. Date of Electronic Publication: 2009 Sep 24.
Autor:
Petersen G; Botanical Garden and Museum, The Natural History Museum of Denmark, University of Copenhagen, Sølvgade 83, DK-1307 Copenhagen K, Denmark. gittep@snm.ku.dk, Seberg O, Yde M, Berthelsen K
Publikováno v:
Molecular phylogenetics and evolution [Mol Phylogenet Evol] 2006 Apr; Vol. 39 (1), pp. 70-82. Date of Electronic Publication: 2006 Feb 28.